APA
DNA icon

American Portfolios Advisors’s Ginkgo Bioworks DNA Stock Holding History

American Portfolios Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$219K Buy
1,758
+104
+6% +$12.4K 0.01% 985
2022
Q2 		$157K Buy
1,654
+453
+38% +$55.3K 0.01% 1159
2022
Q1 		$194K Buy
1,201
+1,129
+1,568% +$220K 0.01% 1169
2021
Q4 		$23.9K Buy
72
+22
+44% +$10.4K ﹤0.01% 2242
2021
Q3 		$23.2K Buy
+50
New +$24.3K ﹤0.01% 2218

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

American Portfolios Advisors's DNA Position: Q3 2022 in Review

American Portfolios Advisors increased its Ginkgo Bioworks (DNA) stake by 6.3% in Q3 2022, buying an estimated $12.4K and bringing the position to 1,758 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #985.

American Portfolios Advisors first reported a position in DNA in Q3 2021 and has held it in 5 quarters since. 278 funds tracked by Wall St. Rank hold DNA as of Q3 2022.

  • American Portfolios Advisors held 1,758 shares of Ginkgo Bioworks worth $219K as of Q3 2022.
  • American Portfolios Advisors bought 104 Ginkgo Bioworks shares in Q3 2022, an estimated $12.4K.
  • Ginkgo Bioworks made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #985 holding.
  • American Portfolios Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 5 quarters since.
  • 278 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.